Veterinary Medicines

Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle

Authorised
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Live
Download as PDF

Product identification

Medicine name:
Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle
Rispoval IBR-Marker Vivum, liofilizatas ir skiediklis injekcinei suspensijai galvijams
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Live
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (calf)
  • Cattle (heifer)
  • Cattle (suckling calf)
Route of administration:
  • Nasal use
  • Nasal use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Live
    10000000.00
    cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Nasal use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
    • Cattle (suckling calf)
      • Meat and offal
        0
        day
  • Nasal use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
    • Cattle (suckling calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • (ID2) 50 Dose; 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 50 Dose and 1 Bottle (Glass) with 100 millilitre(s)
  • (ID1) 10 Dose; 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1795/002-003
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0022/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2022
Download

RV1795.pdf

Lithuanian (PDF)
Published on: 26/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."